Investigating the effect of topical diclofenac in diabetic macular edema

Phase 3

• Conditions: Diabetic macular edema.; Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy with macular edema; E08.331

• Registration Number: IRCT20220423054625N1
• Lead Sponsor: Oroumia University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 November 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Diabetic patients with non-proliferative diabetic retinopathy and diabetic macular edema
Age over 18 years

Exclusion Criteria

Glaucoma patients
Patients with a history of laser therapy
Patients with significant media opacity
Infection and inflammation of the anterior canine of the eye

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Macula central thickness. Timepoint: Before the intervention and one and three months after the intervention. Method of measurement: Optical Coherence Tomography (OCT).;Visual acuity. Timepoint: Before the intervention and one and three months after the intervention. Method of measurement: Snellen chart.

Secondary Outcome Measures

Name	Time	Method
Intraocular pressure. Timepoint: Before the intervention and one and three months after the intervention. Method of measurement: Tonometer.